Ridgewood Investments LLC Has $565,000 Stock Holdings in Core Laboratories Inc. (NYSE:CLB)

Ridgewood Investments LLC increased its holdings in Core Laboratories Inc. (NYSE:CLB) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,612 shares of the oil and gas company’s stock after purchasing an additional 1,428 shares during the period. Ridgewood Investments LLC’s holdings in Core Laboratories were worth $565,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CLB. State Street Corp increased its holdings in shares of Core Laboratories by 2.9% during the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after buying an additional 56,187 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its holdings in shares of Core Laboratories by 446.8% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after buying an additional 3,644,963 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Core Laboratories by 12.5% during the second quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company’s stock worth $6,215,000 after buying an additional 34,149 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Core Laboratories by 0.7% during the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after buying an additional 7,721 shares in the last quarter. Finally, Earnest Partners LLC increased its holdings in shares of Core Laboratories by 6.3% during the second quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after buying an additional 195,756 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLB. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup lowered their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, Core Laboratories has a consensus rating of “Hold” and a consensus price target of $17.00.

Core Laboratories Price Performance

Shares of Core Laboratories stock traded down $0.26 during midday trading on Friday, reaching $17.94. The company had a trading volume of 57,496 shares, compared to its average volume of 243,146. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $842.28 million, a price-to-earnings ratio of 27.60, a price-to-earnings-growth ratio of 1.36 and a beta of 2.39. The stock has a fifty day simple moving average of $19.29 and a 200 day simple moving average of $19.61. Core Laboratories Inc. has a 1-year low of $13.82 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. During the same quarter last year, the business posted $0.22 earnings per share. Core Laboratories’s revenue for the quarter was up 7.2% compared to the same quarter last year. As a group, equities research analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a $0.01 dividend. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.22%. Core Laboratories’s payout ratio is presently 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.